<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the effect of dihydralazine treatment of <z:hpo ids='HP_0000822'>hypertension</z:hpo> in spontaneously hypertensive <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone rats in a model of permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (<z:hpo ids='HP_0001297'>stroke</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>After occlusion of the middle cerebral artery systemic arterial pressure (SAP) was lowered with a computer controlled infusion device from 163 to 135 or 117 mm Hg for 24h </plain></SENT>
<SENT sid="2" pm="."><plain>In the control group SAP was not manipulated </plain></SENT>
<SENT sid="3" pm="."><plain>Reduction of SAP to normotension (117 mm Hg) significantly worsened outcome and increased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume measured 7 days after induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, whereas a mild reduction of SAP (to 137 mm Hg) had no statistically significant effect on outcome or <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that pharmacological treatment of <z:hpo ids='HP_0000822'>hypertension</z:hpo> may negatively affect neurological outcome and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in a rat <z:hpo ids='HP_0001297'>stroke</z:hpo> model </plain></SENT>
</text></document>